Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Joseph Wolk
Age : 54
Public asset : 6,365,154 USD
Country of residence : Unknown
Linked companies : Johnson & Johnson

Biography of Joseph Wolk 
Joseph J. Wolk holds the position of Chief Financial Officer & Executive Vice President at Johnson & Johnson. Mr. Wolk is also Member of Cnbc Global Cfo Council. Mr. Wolk received an undergraduate degree from St. Joseph's University and a graduate degree from Temple University Beasley School of Law.


Current positions of Joseph Wolk 
Holdings of Joseph Wolk 
Joseph Wolk : Personal Network 
Most Read News 
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
08/12MASAYOSHI SON : With Alibaba stake cut, SoftBank's Son cools toward China tech
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
08/02STEPHEN KING : Horror author Stephen King says in publishing trial that consolidation hurts competition
RE
08/01STEPHEN KING : Stephen King goes to bat for U.S. gov't in case against book publishing mega-merger
RE
More news


© 2022 People and Ownership :   
Joseph Wolk : Connections 


Latest news about Joseph Wolk 
07/19Johnson & Johnson Cuts 2022 Outlook on 'Unfavorable' Currency Impact Despite Improved Second-Quarter Performance
MT
07/19TRANSCRIPT : Johnson & Johnson, Q2 2022 Earnings Call, Jul 19, 2022
CI
07/19Johnson & Johnson Seeks Acquisitions
CI
06/21TRANSCRIPT : Johnson & Johnson - Special Call
CI
04/19J&J pulls COVID vaccine sales forecast due to low demand, supply glut
RE
04/19Johnson & Johnson Lowers Full-Year 2022 Outlook on Currency Headwinds Despite First-Quarter Earnings Exceeding Views
MT
04/19TRANSCRIPT : Johnson & Johnson, Q1 2022 Earnings Call, Apr 19, 2022
CI
More news